Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antineoplastic agents 500. Narcistatin.

George R Pettit1, Noeleen Melody, Michael Simpson

  • 1Cancer Research Institute and Department of Chemistry and Biochemistry, Arizona State University, Tempe, Arizona 85287-2404, USA.

Journal of Natural Products
|January 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Controlled Diets High in and Free of Ultraprocessed Food on the Brain of Emerging Adults.

medRxiv : the preprint server for health sciences·2026
Same author

The polygenic architecture of hidradenitis suppurativa reveals signaling mechanisms that implicate epithelial remodeling.

medRxiv : the preprint server for health sciences·2025
Same author

Carbon emission analysis of aortic valve replacement: the environmental footprint of transcatheter vs. surgical procedures.

European heart journal·2025
Same author

A key region of Tau that is able to drive assembly and modulate inhibition by Hydromethylthionine.

Journal of molecular biology·2025
Same author

Characterization of the clinical and photobiologic features of solar urticaria: a UK multicentre cross-sectional study.

The British journal of dermatology·2025
Same author

Concurrent cancer screening participation and associated factors among Canadian women: Insights from a cross-sectional study.

Journal of medical screening·2025
Same journal

Correction to "Structure and Absolute Configuration of Diterpenoids from <i>Hymenaea stigonocarpa</i>".

Journal of natural products·2026
Same journal

Goyangamins A-C, Three Pairs of Enantiomeric 2(1<i>H</i>)-Quinolinone Alkaloid Dimers with Antisenescent Activity from <i>Tetradium daniellii</i>.

Journal of natural products·2026
Same journal

Polycyclic-Fused Cytochalasins with Anti-Liver Fibrosis Activity Produced by the Endophytic Fungus <i>Trichoderma harzianum</i>.

Journal of natural products·2026
Same journal

Oleraciamides A and B: Confirmation and Revision of Structures.

Journal of natural products·2026
Same journal

Synthesis and Stereochemical Revision of Violaceoid E, a Polyoxygenated Cyclohexanoid Natural Product Isolated from <i>Aspergillus violaceofuscus</i> Gasperini.

Journal of natural products·2026
Same journal

Cpumycins A-C, Aminated Benzoic Dimers from <i>Streptomyces</i> sp. CPU-W6, and Their Potential Cardioprotective Activities.

Journal of natural products·2026
See all related articles

Researchers developed an efficient synthesis for narcistatin (3b), a cyclic phosphate derived from the anticancer compound narciclasine (1). Narcistatin and its derivatives show potent anticancer activity comparable to narciclasine against various cancer cell lines.

Area of Science:

  • Medicinal Chemistry
  • Organic Synthesis
  • Pharmacology

Background:

  • Narciclasine (1), an anticancer isocarbostyril from Narcissus species, exhibits limited solubility.
  • Developing soluble and potent anticancer agents is crucial for effective cancer therapy.

Purpose of the Study:

  • To develop an efficient synthetic route for narcistatin (3b), a cyclic phosphate derivative of narciclasine.
  • To evaluate the anticancer activity of narcistatin and its derivatives against human cancer cell lines.

Main Methods:

  • Synthetic conversion of narciclasine (1) using tetrabutylammonium dihydrogen phosphate and p-toluenesulfonic acid in pyridine.
  • Formation of pyridinium narcistatin (3a) and subsequent transformation to water-soluble sodium narcistatin (3d) via cation exchange chromatography.

Related Experiment Videos

  • Anticancer activity assessment using GI(50) values against a panel of human cancer cell lines.

    • Main Results:

    • An efficient procedure for synthesizing narcistatin (3b) from narciclasine (1) was established.
    • Pyridinium narcistatin (3a) was obtained in reasonable yields.
    • Narcistatin (3b) and its 15 salt derivatives demonstrated potent anticancer activity, with GI(50) values ranging from 0.01 to 0.1 μg/mL, comparable to narciclasine.

    Conclusions:

    • Narcistatin (3b) is an accessible cyclic phosphate derivative of narciclasine.
    • Narcistatin and its derivatives retain and potentially enhance the anticancer efficacy of narciclasine.
    • The development of water-soluble prodrugs like sodium narcistatin offers a promising avenue for improved cancer treatment delivery.